Schrödinger, Inc.

As of October 24, 2025, Schrödinger, Inc. shows a neutral technical trend with mixed indicators, having outperformed the S&P 500 recently but underperformed over the longer three and five-year periods.

As of October 24, 2025, Schrödinger, Inc. shows a neutral technical trend with mixed signals, indicating a sideways movement despite some mild bullish indicators on weekly and monthly charts.

As of October 24, 2025, Schrödinger, Inc. shows a neutral technical trend with mixed signals, having outperformed the S&P 500 recently but lagging in longer-term performance.

As of October 3, 2025, Schrödinger, Inc. shows a mildly bearish trend with daily moving averages indicating bearishness, while it has outperformed the S&P 500 recently but underperformed over the past 3 to 5 years.

As of October 3, 2025, Schrödinger, Inc. shows a mildly bearish trend influenced by daily moving averages, while weekly indicators present mixed signals, with recent performance outperforming the S&P 500 short-term but underperforming over the longer term.

As of October 3, 2025, Schrödinger, Inc. has a mildly bearish trend, indicated by daily moving averages, while weekly indicators show mixed signals, with a recent 6.68% return outperforming the S&P 500's 1.09%, but underperforming over the past 3 and 5 years.

As of September 10, 2025, Schrödinger, Inc. has a bearish technical trend with weak strength, indicated by a bearish MACD and moving averages, and has significantly underperformed the S&P 500 with a year-to-date return of 1.87% compared to 12.22%.

As of May 1, 2024, Schrödinger, Inc. is considered risky and overvalued due to negative financial metrics and poor performance, with a Price to Book Value of 4.84, an EV to Sales ratio of 5.69, and a 3-year return of -29.06% compared to the S&P 500's 70.41%.

As of May 1, 2024, Schrödinger, Inc. is considered overvalued and risky due to negative earnings, a high Price to Book Value of 4.84, an EV to EBITDA of -7.03, and significant underperformance compared to peers and the S&P 500.

As of June 13, 2025, the trend is mildly bullish due to daily moving averages and monthly indicators, but caution is advised as weekly MACD and Bollinger Bands show bearish signals, indicating mixed momentum.

As of March 2022, the management team of Schrödinger, Inc. includes Mr. Michael Lynton (Independent Chairman), Dr. Ramy Farid (CEO), and several independent directors: Dr. Richard Friesner, Dr. Rosana Kapeller-Libermann, Mr. Gary Sender, Ms. Nancy Thornberry, and Dr. Timothy Wright. The team features a blend of executive leadership and independent oversight.

Schrödinger, Inc. provides computational software solutions for drug discovery in the biopharmaceutical industry. As of March 2025, it has net sales of $60 million but a net profit loss of $60 million, with a market cap of approximately $1.53 billion.

As of Jun 18, Schrödinger, Inc. has a market capitalization of $1.53 billion, with net sales of $230.49 million and a net profit of -$192.22 million over the latest four quarters.